Literature DB >> 24190760

Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era.

Peter M Vila1, Chaz L Stucken, Luc G T Morris, Marshall R Posner, Eric M Genden, Paolo Boffetta, Andrew G Sikora.   

Abstract

Metastatic lymph nodes (LN) are an adverse prognostic factor in head and neck squamous cell carcinoma (SCC). In this study, we tested the hypothesis that nodal metastases have reduced impact on survival in tonsil cancer in the HPV-predominant era. Incidence and mortality data of tonsil and oral cavity SCC between 1988 and 2007 were obtained from the SEER database. Based on published literature, we considered cases of tonsil cancer from 1988 to 1997 as the pre-HPV cohort (N = 752), and 1998-2007 as the HPV-predominant cohort (N = 2,755). Comparing the two cohorts, Kaplan-Meier 5-year overall survival (OS) for tonsil SCC improved from 54.0 to 74.3 % (p < 0.0001), and cancer-specific survival (CSS) improved from 66.0 to 82.9 % (p < 0.0001). Stratifying by LN involvement showed improved OS in the HPV-predominant cohort with one (63.6 vs. 79.7 %, p < 0.0001), two to three (54.2 vs. 75.9 %, p < 0.0001), four to eight (40.3 vs. 68.9 %, p < 0.0001), and greater than eight positive nodes (25.5 vs. 41.9 %, p < 0.0001). While metastatic LNs still negatively affect prognosis, their impact on OPC survival has diminished in the HPV-predominant era. This finding provides a rationale for additional studies of the prognostic significance of LN metastases in OPC cohorts of defined HPV status, and supports the concept that HPV-related OPC is a disease distinct from "classical" OPC, with unique prognostic features.

Entities:  

Mesh:

Year:  2013        PMID: 24190760      PMCID: PMC4010562          DOI: 10.1007/s00405-013-2796-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

1.  Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma.

Authors:  K Lindel; K T Beer; J Laissue; R H Greiner; D M Aebersold
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

2.  Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer.

Authors:  Lalle Hammarstedt; David Lindquist; Hanna Dahlstrand; Mircea Romanitan; Liselotte Onelöv Dahlgren; Jeanna Joneberg; Nomi Creson; Johan Lindholm; Weimin Ye; Tina Dalianis; Eva Munck-Wikland
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

3.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

4.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

5.  Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor.

Authors:  C R Leemans; R Tiwari; J J Nauta; I van der Waal; G B Snow
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

6.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

7.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

8.  Lymph node prognostic factors in head and neck squamous cell carcinomas.

Authors:  G Mamelle; J Pampurik; B Luboinski; R Lancar; A Lusinchi; J Bosq
Journal:  Am J Surg       Date:  1994-11       Impact factor: 2.565

9.  Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement.

Authors:  K D Olsen; M Caruso; R L Foote; R J Stanley; J E Lewis; S J Buskirk; D A Frassica; L W DeSanto; W M O'Fallon; V R Hoverman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-12

10.  Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma.

Authors:  C R Leemans; R Tiwari; J J Nauta; I van der Waal; G B Snow
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

View more
  2 in total

1.  Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?

Authors:  Ayse Tuba Karagulle Kendi; Kelly Magliocca; Amanda Corey; Dana C Nickleach; James Galt; Kristin Higgins; Jonathan J Beitler; Mark W El-Deiry; J Trad Wadsworth; Patricia A Hudgins; Nabil F Saba; David M Schuster
Journal:  Clin Nucl Med       Date:  2015-03       Impact factor: 7.794

2.  The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies.

Authors:  Małgorzata Wierzbicka; Krzysztof Szyfter; Piotr Milecki; Krzysztof Składowski; Rodryg Ramlau
Journal:  Contemp Oncol (Pozn)       Date:  2015-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.